Dario C Altieri

USPTO Granted Patents = 15 (Patent Applications = 3)

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 1.7

ph-index = 6

Forward Citations = 164(Granted Patents)

Location History:

Hamden, CT (US) (2001 - 2009)
Worcester, MA (US) (2005 - 2018)

Company Filing History:

University of Massachusetts

patents

Years Active: 2001-2018

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9987294 - Mitochondria-targeted anti-tumor agents (2018-06-05),

2. 9035024 - Compounds that inhibit Hsp90 protein-protein interactions with IAP proteins (2015-05-19),

3. 8466140 - Mitochondria-targeted anti-tumor agents (2013-06-18),

4. 8420777 - Compounds that inhibit Hsp90 protein-protein interactions with IAP proteins (2013-04-16),

5. 7794926 - Detection of survivin in the biological fluids of cancer patients (2010-09-14),

6. 7776518 - Detection of survivin in the biological fluids of cancer patients (2010-08-17),

7. 7553821 - Methods for selectively modulating survivin apoptosis pathways (2009-06-30),

8. 7342093 - Compounds that inhibit Hsp90 protein-protein interactions with IAP proteins (2008-03-11),

9. 7097966 - Detection of survivin in the biological fluids of cancer patients (2006-08-29),

10. 6949558 - Enhancement of taxane-based chemotherapy by a CDK1 antagonist (2005-09-27),

11. 6943150 - Survivin, a protein that inhibits cellular apoptosis and its modulation (2005-09-13),

12. 6800737 - Survivin, a protein that inhibits cellular apoptosis, and its modulation (2004-10-05),

13. 6509162 - Methods for selectively modulating survivin apoptosis pathways (2003-01-21),

14. 6346389 - Method for selectively modulating the interactions between survivin and tubulin (2002-02-12),

15. 6245523 - Survivin, a protein that inhibits cellular apoptosis, and its modulation (2001-06-12),

Title: Dario C Altieri: Innovator in Anti-Tumor Research

Introduction

Dario C Altieri is a prominent inventor based in Worcester, MA (US). He has made significant contributions to the field of cancer research, particularly in the development of anti-tumor agents. With a total of 15 patents, Altieri's work focuses on innovative solutions for treating disorders associated with unwanted cell proliferation.

Latest Patents

Among his latest patents, Altieri has developed mitochondria-targeted anti-tumor agents. These agents are designed to treat disorders linked to unwanted cell growth. Additionally, he has disclosed compounds that inhibit Hsp90 protein-protein interactions with IAP proteins. This includes methods for identifying and utilizing such compounds, which target proteins like Survivin, XIAP, cIAP1, or cIAP2.

Career Highlights

Throughout his career, Dario C Altieri has worked with esteemed institutions such as Yale University and the University of Massachusetts. His research has been pivotal in advancing the understanding of cancer biology and therapeutic strategies.

Collaborations

Altieri has collaborated with notable colleagues, including Janet Plescia and Whitney Salz. Their combined efforts have contributed to the development of innovative cancer treatments.

Conclusion

Dario C Altieri's work exemplifies the impact of innovative research in the fight against cancer. His patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.